Literature DB >> 16082162

Amphipathic alpha-helix mediates the heterodimerization of soluble guanylyl cyclase.

Takumi Shiga1, Norio Suzuki.   

Abstract

Soluble guanylyl cyclase (soluble GC) is an enzyme consisting of alpha and beta subunits and catalyzes the conversion of GTP to cGMP. The formation of the heterodimer is essential for the activity of soluble GC. Each subunit of soluble GC has been shown to comprize three functionally different parts: a C-terminal catalytic domain, a central dimerization domain, and an N-terminal regulatory domain. The central dimerization domain of the beta(1) subunit, which contains an N-terminal binding site (NBS) and a C-terminal binding site (CBS), has been postulated to be responsible for the formation of alpha/ beta heterodimer. In this study, we analyzed heterodimerization by the pull-down assay using the affinity between a histidine tag and Ni(2+) Sepharose after co-expression of various N- and C-terminally truncated FLAG-tagged mutants of the alpha(1) subunit and the histidine-tagged wild type of the beta(1) subunit in the vaculovirus/Sf9 system, and demonstrated that the CBS-like sequence of the alpha(1) subunit is critical for the formation of the heterodimer with the beta(1) subunit and the NBS-like sequence of the alpha(1) subunit is essential for the formation of the enzymatically active heterodimer, although this particular sequence was not involved in heterodimerization. The analysis of the secondary structure of the alpha(1) subunit predicted the existence of an amphipathic alpha-helix in residues 431-464. Experiments with site-directed alpha(1) subunit mutant proteins demonstrated that the amphipathicity of the alpha-helix is important for the formation of the heterodimer, and Leu(463) in the alpha-helix region plays a critical role in the formation of a properly arranged active center in the dimer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082162     DOI: 10.2108/zsj.22.735

Source DB:  PubMed          Journal:  Zoolog Sci        ISSN: 0289-0003            Impact factor:   0.931


  7 in total

1.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

2.  Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.

Authors:  Iraida G Sharina; Filip Jelen; Elena P Bogatenkova; Anthony Thomas; Emil Martin; Ferid Murad
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

3.  Fluorescent fusion proteins of soluble guanylyl cyclase indicate proximity of the heme nitric oxide domain and catalytic domain.

Authors:  Tobias Haase; Nadine Haase; Jan Robert Kraehling; Soenke Behrends
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

4.  PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure.

Authors:  Xiaolei Ma; Nazish Sayed; Padmamalini Baskaran; Annie Beuve; Focco van den Akker
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

5.  The amino-terminus of nitric oxide sensitive guanylyl cyclase α₁ does not affect dimerization but influences subcellular localization.

Authors:  Jan R Kraehling; Mareike Busker; Tobias Haase; Nadine Haase; Markus Koglin; Monika Linnenbaum; Soenke Behrends
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

6.  Crystal structure of the signaling helix coiled-coil domain of the beta1 subunit of the soluble guanylyl cyclase.

Authors:  Xiaolei Ma; Annie Beuve; Focco van den Akker
Journal:  BMC Struct Biol       Date:  2010-01-27

7.  Interfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity.

Authors:  Franziska Seeger; Royston Quintyn; Akiko Tanimoto; Gareth J Williams; John A Tainer; Vicki H Wysocki; Elsa D Garcin
Journal:  Biochemistry       Date:  2014-03-26       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.